FOXO3 and cancer: Given that the proteasome was identified as a common target in multiple oncogenic RAS synthetic lethal genetic screens,45, 46, 47 we hypothesized that RAS-mutant cancer cells also enhance proteasome activity to maintain proper proteostasis and to eradicate growth suppressors like FOXO3A and FOXO4.